Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta

Ann Neurol. 1994 Jul;36(1):14-8. doi: 10.1002/ana.410360106.
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic / methods*
  • Clinical Trials, Phase III as Topic / methods
  • Humans
  • Interferon-beta / therapeutic use*
  • Magnetic Resonance Imaging*
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Probability
  • Research Design
  • Treatment Outcome

Substances

  • Interferon-beta